NASDAQ:GHSI Guardion Health Sciences (GHSI) Stock Price, News & Analysis → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free GHSI Stock Alerts $9.01 -0.01 (-0.11%) (As of 02:21 PM ET) Add Compare Share Share Today's Range$8.95▼$9.0150-Day Range$5.15▼$9.0952-Week Range$4.99▼$10.75Volume2,720 shsAverage Volume227,436 shsMarket Capitalization$11.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Guardion Health Sciences alerts: Email Address Ad Crypto Swap ProfitsGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Guardion Health Sciences Stock (NASDAQ:GHSI)Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.Read More GHSI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GHSI Stock News HeadlinesMarch 28, 2024 | finance.yahoo.comGHS Label Market Set to Achieve Steady Growth with a 3.4% CAGR through 2034 | Future Market Insights Inc.March 26, 2024 | americanbankingnews.comGuardion Health Sciences (NASDAQ:GHSI) Stock Price Down 0.9%March 28, 2024 | Crypto Swap Profits (Ad)Grab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.February 24, 2024 | msn.comGuardion Health Sciences (GHSI) Price Target Increased by 233.33% to 40.80February 1, 2024 | realmoney.thestreet.comMaxim gets more bearish on Guardion Health Sciences, downgrades sharesFebruary 1, 2024 | msn.comWhy Guardion Health Sciences Stock Is Up TodayFebruary 1, 2024 | msn.comGuardion Health Sciences Sells Activ to Doctor’s BestJanuary 31, 2024 | marketwatch.comGuardion Health Shares Soar Premarket on Deal to Sell ViactivMarch 28, 2024 | Crypto Swap Profits (Ad)Grab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.January 31, 2024 | markets.businessinsider.comWhy Is Guardion Health (GHSI) Stock Up 66% Today?January 30, 2024 | finance.yahoo.comGuardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.November 22, 2023 | msn.comKadjebi GHS exceeds SMC registration, dosing targetNovember 13, 2023 | finance.yahoo.comGuardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023November 6, 2023 | msn.comGHS to launch “ART at 20 celebrations” to showcase impact on livesAugust 25, 2023 | markets.businessinsider.comMaxim Group Sticks to Their Buy Rating for Guardion Health Sciences (GHSI)August 14, 2023 | finance.yahoo.comGuardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023July 1, 2023 | finance.yahoo.comGHSI - Guardion Health Sciences, Inc.June 28, 2023 | finance.yahoo.comGuardion Health Sciences Insider Ups Holding By 115% During YearMay 30, 2023 | seekingalpha.comGuardion Health Sciences appoints president and CEOMay 30, 2023 | finance.yahoo.comGuardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive OfficerMay 19, 2023 | markets.businessinsider.comMaxim Group Keeps Their Buy Rating on Guardion Health Sciences (GHSI)May 15, 2023 | msn.comGuardion Health Sciences GAAP EPS of $0.42, revenue of $3.19MMay 15, 2023 | finance.yahoo.comGuardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023April 19, 2023 | finance.yahoo.comGuardion Health Sciences, Inc.'s (NASDAQ:GHSI) Shares Leap 29% Yet They're Still Not Telling The Full StoryApril 17, 2023 | finance.yahoo.comGuardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022March 29, 2023 | benzinga.comGuardion Health Sciences Stock (NASDAQ:GHSI), DividendsMarch 6, 2023 | finance.yahoo.comGuardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder ValueSee More Headlines Receive GHSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/12/2019Today3/28/2024Next Earnings (Estimated)4/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:GHSI CUSIPN/A CIK1642375 Webwww.guardionhealth.com Phone(800) 873-5141Fax858-630-5543Employees12Year Founded2009Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,920,000.00 Net Margins-105.66% Pretax Margin-105.66% Return on Equity-162.33% Return on Assets-81.46% Debt Debt-to-Equity RatioN/A Current Ratio8.97 Quick Ratio7.25 Sales & Book Value Annual Sales$11.05 million Price / Sales1.04 Cash Flow$5.24 per share Price / Cash Flow1.72 Book Value$6.43 per share Price / Book1.40Miscellaneous Outstanding Shares1,280,000Free Float1,258,000Market Cap$11.53 million OptionableNot Optionable Beta0.87 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Robert Neal Weingarten (Age 72)Independent Chairman & Secretary Comp: $79kMr. Craig J. Sheehan (Age 53)Chief Commercial Officer Comp: $256.88kMs. Janet Hall (Age 65)President & CEO Ms. Katie Cox (Age 54)Chief Accounting Officer Key CompetitorsAddex TherapeuticsNASDAQ:ADXNJanOneNASDAQ:JANAgeX TherapeuticsNYSE:AGEElevai LabsNASDAQ:ELABImunonNASDAQ:IMNNView All Competitors GHSI Stock Analysis - Frequently Asked Questions Should I buy or sell Guardion Health Sciences stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Guardion Health Sciences in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GHSI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GHSI, but not buy additional shares or sell existing shares. View GHSI analyst ratings or view top-rated stocks. How have GHSI shares performed in 2024? Guardion Health Sciences' stock was trading at $5.34 at the start of the year. Since then, GHSI stock has increased by 68.7% and is now trading at $9.01. View the best growth stocks for 2024 here. When is Guardion Health Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, April 15th 2024. View our GHSI earnings forecast. How were Guardion Health Sciences' earnings last quarter? Guardion Health Sciences, Inc. (NASDAQ:GHSI) released its quarterly earnings data on Monday, August, 12th. The company reported ($42.00) EPS for the quarter. The company had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative net margin of 105.66% and a negative trailing twelve-month return on equity of 162.33%. When did Guardion Health Sciences' stock split? Guardion Health Sciences's stock reverse split on Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. What other stocks do shareholders of Guardion Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Ocugen (OCGN), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX) and FuelCell Energy (FCEL). When did Guardion Health Sciences IPO? Guardion Health Sciences (GHSI) raised $6 million in an initial public offering (IPO) on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO. How do I buy shares of Guardion Health Sciences? Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GHSI) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeAI to Meet the Same Fate as EVs? Porter & CompanyGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardion Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.